StonvexLoading…
StonvexStonvexStonvexCore line items from FNMA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $28.96B | $29.07B | $29.05B | $29.73B |
Operating Income | $17.98B | $21.27B | $21.96B | $16.23B |
Net Income | $14.36B | $16.98B | $17.41B | $12.92B |
EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
Total Assets | $4.32T | $4.35T | $4.33T | $4.31T |
Total Liabilities | $4.21T | $4.26T | $4.25T | $4.25T |
Cash & Equivalents | $42.58B | $38.85B | $35.82B | $57.99B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 1.16B | 1.16B | 1.16B | 1.16B |